About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Clinical Trials in Ohio | 28,710 Studies Near You

Clinical TrialsOhio

Clinical Trials in Ohio

Discover 28,710 clinical trials near Ohio. Find research studies in your area.

Browse by condition:

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma Pancreatic Cancer

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 3961-3980 of 28,710 trials

RecruitingStrokeNet Thrombectomy Endovascular PlatformSTEP is a Randomized, Multifactorial, Adaptive Platform trial that seeks to optimize the care of patients with acute ischemic stroke (AIS) due to large (LVO) or medium vessel…NCT06289985·Birmingham, Alabama and 40 others

Find Trials by Condition in Ohio

Breast Cancerin Ohio Lung Cancerin Ohio Prostate Cancerin Ohio Colorectal Cancerin Ohio Melanomain Ohio Leukemiain Ohio Lymphomain Ohio Pancreatic Cancerin Ohio Ovarian Cancerin Ohio Brain Cancerin Ohio Diabetesin Ohio

Data from ClinicalTrials.govTerms

TerminatedOpen-Label Extension of EryDex Study IEDAT-04-2022This is an international, multi-center, prospective, open-label, non-comparative study aiming to provide access to treatment with EryDex to ataxia telangiectasia (A-T) patients…NCT06664853·Los Angeles, California and 20 others

CompletedBridge Occlusion Balloon in Lead Extraction ProcedureTo evaluate the use of an occlusion balloon (Bridge™ Occlusion Balloon, Spectranetics) within the Superior Vena Cava in lead extraction patients.NCT02714153·Miami, Florida and 6 others

CompletedEfficacy and Safety of Omalizumab in Children (6 - < 12 Years) With Moderate-severe, Inadequately Controlled Allergic AsthmaA substance called immunoglobulin E (IgE), which is naturally produced by our body, has a key role in generating asthma attacks.NCT00079937·Birmingham, Alabama and 55 others

CompletedComparison of Tiotropium in the HandiHaler Versus the Respimat in Chronic Obstructive Pulmonary DiseaseDirect comparison studies of the tiotropium HandiHaler® 18 µg and Respimat® 5 µg formulations have been limited to 4-week crossover studies.NCT01126437·Athens, Alabama and 1190 others

Active not recruitingSurVaxM Vaccine Therapy and Temozolomide in Treating Patients With Newly Diagnosed GlioblastomaThis phase II trial studies the side effects and how well vaccine therapy works when given together with temozolomide in treating patients with newly diagnosed glioblastoma.NCT02455557·Boston, Massachusetts and 4 others

CompletedS0720: Adjuvant Therapy Based on Gene Expression in Stage IA and IB Non-Small Cell Lung CancerRATIONALE: Drugs used in chemotherapy, such as gemcitabine and cisplatin, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them…NCT00792701·Fort Smith, Arkansas and 146 others

TerminatedEverolimus and Bortezomib in Treating Patients With Relapsed or Refractory LymphomaRATIONALE: Everolimus and bortezomib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth.NCT00671112·Cleveland, Ohio

RecruitingA Study of GEn-1124 in Subjects With Acute Respiratory Distress Syndrome (ARDS)GEn1E-1124-002 is a two-part Phase 2 study to evaluate the safety and tolerability of GEn-1124 in subjects with ARDS.NCT05795465·Washington D.C., District of Columbia and 10 others

CompletedEffects of Changing HIV Therapy at Lower Versus Higher Viral LoadsThis study will look at people who have been taking anti-HIV drugs but still have detectable levels of HIV.NCT00036465·Menlo Park, California and 22 others

CompletedAn Open-Label, 2-Cohort, Multicenter, Study of Lenvatinib in Previously Treated Subjects With Unresectable Stage III or Stage IV MelanomaThe purpose of this study is to assess the objective response rate of lenvatinib in previously treated participants with American Joint Committee on Cancer (AJCC) unresectable…NCT01136967·Birmingham, Alabama and 94 others

UnknownCirculating Tumor Cells and Survival in Hormone Refractory Prostate Cancer (HRPC) Patients Receiving ChemotherapyThis study enrolled men with prostate cancer who had failed hormone therapy (as shown by rising prostate-specific antigen \[PSA\] levels) and who were about to start a new line of…NCT00133900·Cleveland, Ohio

SuspendedTesting the Addition of an Anti-cancer Drug, ASTX727 (Cedazuridine, Decitabine), to Chemotherapy (Paclitaxel) and Immunotherapy (Pembrolizumab) for Metastatic Triple-Negative Breast CancerThis phase I trial tests the safety, side effects, and best dose of ASTX727 when given in combination with a usual approach of treatment with paclitaxel and pembrolizumab in…NCT05673200·Phoenix, Arizona and 9 others

TerminatedA Study to Learn About a Modified RNA Vaccine Against Shingles in Healthy AdultsThe purpose of this clinical study is to learn about the safety, extent of the side effects (reaction to vaccine), and immune response (your immune system's reaction) of the study…NCT05703607·Gilbert, Arizona and 34 others

CompletedA Trial to Evaluate the Efficacy and Safety of Formoterol Fumarate 20 Mcg/0.5 mL in the Treatment of Patients With COPDThe purpose of this study is to determine the safety and efficacy of the investigational drug in comparison with a placebo.NCT00280371·Jasper, Alabama and 51 others

CompletedArestin - Use in Subjects With Peri-ImplantitisThe objective of the study is to evaluate the safety and effectiveness of Arestin (minocycline HCl) 1 mg Microspheres in the treatment of subjects with peri-implantitis, when used…NCT01539564·Los Angeles, California and 11 others

CompletedStudy to Assess the Efficacy and Safety of Orismilast in Atopic Dermatitis (ADESOS)This study investigates 3 different doses of orismilast modified release compared to placebo in adult patients with moderate-to-severe atopic dermatitis.NCT05469464·Canoga Park, California and 47 others

AvailableIntermediate-Size Expanded Access Protocol (EAP) for LP352This is an intermediate-size expanded access program (EAP) study.NCT06149663·Downey, California and 21 others

TerminatedFrequency of Residual Neuromuscular Blockade in the Pediatric PopulationThis study is designed to investigate the frequency of Residual Neuromuscular Blockade (RNMB) in the pediatric population.NCT01786863·Columbus, Ohio

TerminatedRanolazine Cardioprotection in PCIThe investigators will test if upfront dosing of Ranolazine can reduce myocardial biomarker release (CK-MB, Troponin) post percutaneous coronary intervention (PCI).NCT01767987·Kettering, Ohio

PreviousPage 199 of 1436Next

Heart Diseasein Ohio